Regulatory report: US state discounts and benefits for MRTPs

The term “modified risk tobacco product” means any tobacco product that is sold or distributed for use to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products. In order to market tobacco products in such manner, an order issued by the Food and Drug Administration (FDA) must be obtained first.

Tax discounts for MRTPs usually differentiates between risk modification orders (RMO) and exposure modification orders (EMO). This report analyses whether US states are considering the different harm profiles of tobacco products when taxing them, in order to encourage consumption of lower risk products.